Solid Tumors Websites
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.
2,663,576
$
480.00
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer an
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
3,446,235
$
480.00
Kereos | Targeted Therapeutics and Molecular Imaging
Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease earlier and more specifically than currently possible.
Not Applicable
$
8.95
Oncothyreon
Oncothyreon is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients.
4,256,068
$
240.00
Andarix Pharmaceuticals, Inc.
Andarix Pharmaceuticals is a clinical stage company developing a targeted personalized treatment for lung, breast and other cancers based on a proprietary somatostatin peptide conjugate (P2045). Extensive research has demonstrated that Somatostatin receptors are highly up-regulated on several solid tumors, particularly
Not Applicable
$
8.95
Solid Tumor Translational Research
Together Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance are bridging laboratory sciences and patient care to provide the most precise treatment options for patients with solid tumor cancers.
Not Applicable
$
8.95
Solid Tumor Translational Research
Together Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance are bridging laboratory sciences and patient care to provide the most precise treatment options for patients with solid tumor cancers.
Not Applicable
$
8.95
Solid Tumor Translational Research
Together Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance are bridging laboratory sciences and patient care to provide the most precise treatment options for patients with solid tumor cancers.
Not Applicable
$
8.95
Seattle Translational Tumor Research
Seattle Translational Tumor Research - Together Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance are bridging laboratory sciences and patient care to provide the most precise treatment options for patients with solid tumor cancers.
Not Applicable
$
8.95
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.
Not Applicable
$
8.95
Cend Therapeutics
Breaking the Barriers of Anti-Cancer Drug Delivery to Solid Tumors
Not Applicable
$
8.95
CASINVENT - Highly Potent and Selective Inhibitors of CK1 Kinases
Highly Potent and Selective Inhibitors of CK1 Kinases for the Treatment of Leukaemias, Lymphomas and Solid Tumors
Not Applicable
$
8.95
TTFields Therapy
TTFields therapy is an innovative, electric fields-based modality for solid tumor treatment
Not Applicable
$
8.95
